Arrow Financial’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-125
| Closed | -$22.2K | – | 180 |
|
|
2024
Q3 | $22.2K | Sell |
125
-125
| -50% | -$22.2K | ﹤0.01% | 258 |
|
|
2024
Q2 | $42.1K | Hold |
250
| – | – | ﹤0.01% | 218 |
|
|
2024
Q1 | $41.6K | Hold |
250
| – | – | ﹤0.01% | 214 |
|
|
2023
Q4 | $41.3K | Hold |
250
| – | – | ﹤0.01% | 221 |
|
|
2023
Q3 | $38.9K | Hold |
250
| – | – | ﹤0.01% | 218 |
|
|
2023
Q2 | $39K | Hold |
250
| – | – | ﹤0.01% | 215 |
|
|
2023
Q1 | $40.5K | Hold |
250
| – | – | 0.01% | 216 |
|
|
2022
Q4 | $40K | Hold |
250
| – | – | 0.01% | 226 |
|
|
2022
Q3 | $35K | Hold |
250
| – | – | 0.01% | 224 |
|
|
2022
Q2 | $36K | Hold |
250
| – | – | ﹤0.01% | 223 |
|
|
2022
Q1 | $41K | Hold |
250
| – | – | ﹤0.01% | 228 |
|
|
2021
Q4 | $47K | Hold |
250
| – | – | 0.01% | 213 |
|
|
2021
Q3 | $51K | Hold |
250
| – | – | 0.01% | 211 |
|
|
2021
Q2 | $50K | Hold |
250
| – | – | 0.01% | 212 |
|
|
2021
Q1 | $44K | Hold |
250
| – | – | 0.01% | 216 |
|
|
2020
Q4 | $42K | Hold |
250
| – | – | 0.01% | 206 |
|
|
2020
Q3 | $41K | Hold |
250
| – | – | 0.01% | 201 |
|
|
2020
Q2 | $41K | Hold |
250
| – | – | 0.01% | 212 |
|
|
2020
Q1 | $32K | Hold |
250
| – | – | 0.01% | 228 |
|
|
2019
Q4 | $35K | Hold |
250
| – | – | 0.01% | 239 |
|
|
2019
Q3 | $29K | Hold |
250
| – | – | 0.01% | 244 |
|
|
2019
Q2 | $32K | Hold |
250
| – | – | 0.01% | 251 |
|
|
2019
Q1 | $32K | Hold |
250
| – | – | 0.01% | 250 |
|
|
2018
Q4 | $28K | Hold |
250
| – | – | 0.01% | 246 |
|
|
2018
Q3 | $34K | Hold |
250
| – | – | 0.01% | 246 |
|
|
2018
Q2 | $30K | Hold |
250
| – | – | 0.01% | 235 |
|
|
2018
Q1 | $30K | Hold |
250
| – | – | 0.01% | 241 |
|
|
2017
Q4 | $31K | Hold |
250
| – | – | 0.01% | 234 |
|
|
2017
Q3 | $34K | Hold |
250
| – | – | 0.01% | 229 |
|
|
2017
Q2 | $31K | Hold |
250
| – | – | 0.01% | 238 |
|
|
2017
Q1 | $30K | Hold |
250
| – | – | 0.01% | 238 |
|
|
2016
Q4 | $27K | Hold |
250
| – | – | 0.01% | 243 |
|
|
2016
Q3 | $29K | Hold |
250
| – | – | 0.01% | 237 |
|
|
2016
Q2 | $26K | Hold |
250
| – | – | 0.01% | 243 |
|
|
2016
Q1 | $26K | Hold |
250
| – | – | 0.01% | 246 |
|
|
2015
Q4 | $32K | Hold |
250
| – | – | 0.01% | 235 |
|
|
2015
Q3 | $29K | Hold |
250
| – | – | 0.01% | 223 |
|
|
2015
Q2 | $34K | Hold |
250
| – | – | 0.01% | 222 |
|
|
2015
Q1 | $32K | Hold |
250
| – | – | 0.01% | 225 |
|
|
2014
Q4 | $29K | Hold |
250
| – | – | 0.01% | 229 |
|
|
2014
Q3 | $26K | Hold |
250
| – | – | 0.01% | 251 |
|
|
2014
Q2 | $24K | Hold |
250
| – | – | 0.01% | 255 |
|
|
2014
Q1 | $23K | Buy |
+250
| New | +$24.3K | 0.01% | 251 |
|
Other funds holding BBH
MIM
TWC
Arrow Financial's BBH Position: Q4 2024 in Review
Arrow Financial sold out of VanEck Biotech ETF (BBH) in Q4 2024, closing a stake of 125 shares — an estimated $22.2K sold.
Arrow Financial first reported a position in BBH in Q1 2014 and held it in 43 quarters. The position peaked at $51K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q4 2024.
- Arrow Financial reported no remaining VanEck Biotech ETF position as of Q4 2024 after selling out during the quarter.
- Arrow Financial sold 125 VanEck Biotech ETF shares in Q4 2024, an estimated $22.2K.
- Arrow Financial first reported a position in VanEck Biotech ETF in Q1 2014 and held it in 43 quarters.
- Arrow Financial's VanEck Biotech ETF position peaked at $51K in Q3 2021.
- 115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2024.
Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.